Nuclear factor kappa-B and the heart

Journal of the American College of Cardiology

Volumn 38, Issue 2, 2001, Pages 307-314

  Valen, Guro ^a   Yan, Zhong Qun ^a   Hansson, Göran K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; HEART; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW;

EID: 0034908292     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01377-8     Document Type: Article

References (118)

1. NFκB: A pivotal role in asthma and a new target for therapy
2. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of disease
3. NF-κB and REL proteins: Evolutionarily conserved mediators of immune responses
4. The nuclear factor kappa-B/inhibitor of kappa-B autoregulatory system and antherosclerosis
5. Is NF-κB the sensor of oxidative stress?
6. Early activation of transcription factor NF-κB during ischemia in perfused rat heart
7. Nuclear factor-κB is activated by hyperoxia but does not protect from cell death
8. Site-specific phosphorylation of I-kappa-B-alpha by a novel ubiquitination-dependent protein kinase activity
9. A cytokine-responsive I-kappa-B kinase that activates the transcription factor NF-kappa-B
10. IKK-1 and IKK-2: Cytokine-activated I-kappa-B kinases essential for NF-kappa-B activation
11. The I-kappa-B kinase complex (IKK) contains two kinase subunits, IKK-alpha and IKK-beta, necessary for I-kappa-B phosphorylation and NF-kappa-B activation
12. Complementation cloning of NEMO, a component of the I-kappa-B kinase complex essential for NF-kappa-B activation
13. IKK-gamma is an essential regulatory subunit of the I-kappa-B kinase complex
14. I-kappa-B kinase (IKK)-associated protein I, a common component of the heterogeneous IKK complex
15. Identification ora cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor-alpha-induced apoptosis
16. Identification and characterization of an I-kappa-B kinase
17. NF-kappaB-inducing kinase activates IKK-alpha by phospborylation of Set-176
18. MEKK1 activates both I-kappa-B kinase alpha and I-kappa-B kinase beta
19. The beginning of the end: I-kappa-B kinase (IKK) and NF-kappaB activation
20. IKK-epsilon is part of a novel PMA-inducible Ikappa-B kinase complex
21. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases
22. NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphoryation
23. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor-kB independently of IkB degradation
24. IκB-NF-κB Structures: At the interface of inflammation control
25. The NF-κB and IκB proteins: New discoveries and insights
26. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa-B and cytokine-inducible enhancers
27. Identification of an inducible endothelial-leukocyte adhesion molecule
28. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells
29. Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells
30. Interleukin-1: A mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids
31. Adult human vascular endothelial cells express the IL-6 gene differentially in response to LPS or IL
32. Proliferating or interleukin-1-activated human vascular smooth muscle cells secrete copious interleukin-6
33. Cytokines and endothelial cell biology
34. Interleukin-1 induces interleukin-1. II. Recombinant human interleukin-1 induces interleukin-1 production by adult human vascular endothelial cells
35. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF)
36. Innate immunity: The virtues of a nonclonal system of recognition
37. Toll-like receptors in the induction of the innate immune response
38. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not
39. Suppression of TNF-α-induced apoptosis by NF-κB
40. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B
41. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ tumor necrosis factor-α and interleukin-1β
42. Vascular smooth muscle cells express a constitutive NF-kappa B-like activity
43. Nuclear factor-kappa-B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells
44. Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu(2+) and Zn(2+)
45. An essential role for NF-κB in preventing TNF-α-induced cell death
46. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
47. Nuclear factor (NF)-kappa-B-regulated X-chromosome-linked lap gene expression protects endothelial cells from tumor necrosis factor-alpha-induced apoptosis
48. Differential regulation of Bcl-2, AP-1, and NFκB on cardiomyocyte apoptosis during myocardial ischemic stress adaption
49. Linkage of the BH4 domain of Bcl-2 and the nuclear factor-κB signaling pathway for suppression of apoptosis
50. Activation of a pro-apoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP
51. NF-kappaB is activated and promotes cell death in focal cerebral ischemia
52. Severe liver degeneration in mice lacking the IkappaB kinase-2 gene
53. IKK1-deficient mice exhibit abnormal development of skin and skeleton
54. Embryonic lethality, liver degeneration, and impaired NF-kappa-B activation in IKK-beta -deficient mice
55. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells
56. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa B
57. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB
58. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma - The role of constitutive NF-Kappa-B activity
59. Early activation of transcription factor NF-kB during ischemia in perfused rat heart
60. Induction of nuclear factor kB and activation protein-1 in postischemic myocardium
61. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats
62. Induction of inflammatory mediators during reperfusion of the human heart
63. The leukocyte cell adhesion cascade and its role in myocardial ischemia-reperfusion injury
64. Therapeutic strategies to reduce TNF-α-mediated cardiac contractile depression following ischemia and reperfusion
65. Prevention of myocardial reperfusion injury, in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1
66. In vivo transfection of els element "decoy" against nuclear factor-κB binding site prevents myocardial infarction
67. A novel strategy for myocardial protection using in vivo transfection of cis element "Decoy" against NFκB binding site
68. Myocardial nuclear factor-κB activity and nitric oxide production in rejecting cardiac allografts
69. Nuclear factor-κB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits
70. An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischaemia
71. An essential role for NFκB in the cardioadaptive response to ischemia
72. Signal transduction in ischemic preconditioning
73. Reactive oxygen species function as second messenger during ischemic preconditioing of heart
74. ATP and ADP activate transcription factor NF-kappaB and induce endothelial cell apoptosis
75. Oxidative stress increases adenosine A1 receptor expression by activating nuclear factor kappa-B
76. Adenosine prevents activation of transcription factor NF-κB and enhances activator protein-1 binding activity in ischemic rat heart
77. Delayed cardioprotection in a human cardiomyocyte-derived cell line: The role of adenosine, p38MAP kinase and mitochondrial KATP
78. Adenosine A(1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase
79. The nitric oxide hypothesis of delayed preconditioning
80. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: Evidence from gene-knockout animals
81. CyclooxTgenase-2 mediates the cardloprotective effects of the late phase of ischemic preconditioning in conscious rabbits
82. The late phase of ischemic preconditioing is abrogated by targeted disruption of the inducible NO synthase gene
83. Hyperoxia elicits preconditioning through a NFκB-dependent mechanism in the rat heart
84. Endothelial preconditioning by transient oxidative stress reduces inflammatory, responses of cultured endothelial cells to TNF-alpha
85. Cardiac stress protein elevation 24 hours after brief ischaemia or heat stress is associated with resistance to myocardial infarction
86. Modulation of cellular AP-1 DNA binding activity by heat shock proteins
87. Tobacco smoke induces coordinate activation of HSF and inhibition of NFkappaB in human monocytes: Effects on TNFalpha release
88. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in sim hybridization
89. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite
90. Cytokine expression in advanced human atherosclerotic plaques: Dominance of proinflammatory (Th1) and macrophage-stimulating cytokines
91. The nuclear factor κ-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis
92. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion
93. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression
94. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55
95. Molecular basis of the acute coronary syndromes
96. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease
97. Detection of activated T lymphocytes in the human atherosclerotic plaque
98. Interleukin-6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits
99. Local expression of inflammatory cytokines in human atherosclerotic plaques
100. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
101. Elevated levels of interleukin-6 in unstable angina
102. Prognostic value of C-reactive protein and plasma amyloid A protein in severe unstable angina
103. Inflammation, atherosderosis, and ischemic events - Exploring the hidden side of the moon
104. Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris
105. Pericardial fluid from patients with unstable angina induces vascular endothelial cell apoptosis
106. Role of smooth muscle cell death in advanced coronary primary lesions: Implications for plaque instability
107. Previous angina alters in-hospital outcome in TIMI-4. A clinical correlate to preconditioning?
108. Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFκB and AP-1
109. Mortality and myocardial infarction after coronary artery surgery
110. The inflammatory response and extracorporeal circulation
111. Induction of cyclooxygenase-2 and activation of nuclear factor kappaB in myocardium of patients with congestive heart failure
112. Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway
113. Heterogenous expression and activity, of endothelial and inducible nitric oxide synthase in end-stage human heart failure; their relation to lesion site and beta-adrenergic receptor therapy
114. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomypathy
115. Upregulation of cell adhesion molecules and the presence of low-graded inflammation in human chronic heart failure
116. Expression of inducible nitric oxide synthase in human heart failure
117. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
118. Role of TLR-2 in the activation of nuclear factor-kappa-B by oxidative stress in cardiac myocytes